申请人:Baumann Karlheinz
公开号:US20080280948A1
公开(公告)日:2008-11-13
The invention relates to compounds of formula
wherein hetaryl I, hetaryl II, and R
1
are as described herein. Compounds of formula I are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposition of β-amyloid in the brain, in particular Alzheimer's disease.
该发明涉及公式的化合物,其中hetaryl I、hetaryl II和R1如本文所述。公式I的化合物是淀粉样蛋白β的调节剂,因此它们可能对与大脑中β-淀粉样蛋白沉积相关的疾病的治疗或预防有用,特别是阿尔茨海默病。